Eli Lilly Alzheimer's Drug Slows Mental Decline, Study Finds

Lilly Alzheimer's Drug Slows Mental Decline, Study Finds
Bloomberg
Eli Lilly & Co. (LLY)'s experimental Alzheimer's treatment slowed memory loss and cognitive decline in early-stage patients by about 30 percent, offering the first evidence that a medication may hamper the course of the ailment, researchers said.

In Depth:New Data Released on Lilly Alzheimer's Drug



Sponsored Links: